HR

Habibar Rahman

Active Director Director DIN 10465361
DIN 10465361 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Habibar Rahman

Data last updated:

Habibar Rahman is a Director at Radial Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Radial Pharmaceuticals Private Limited reported revenue of ₹25.8 Lakh (FY 2025).

DIN 10465361
Primary Designation Director
Industry Pharma
First Appointment 20 Jan 2024
Oldest Company Age 2 yrs
Largest company Radial Pharmaceuticals Private Limited · ₹25.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20242024₹25.8 Lakh (FY 2025)Active

Board colleagues of Habibar Rahman

Directorship timeline

Open interactive timeline →
Radial Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Habibar Rahman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Habibar Rahman

Habibar Rahman currently holds 1 directorship: Radial Pharmaceuticals Private Limited (Director, since 20 Jan 2024, revenue ₹25.8 Lakh (FY 2025)).

Habibar Rahman was first appointed on 20 Jan 2024 as Director at Radial Pharmaceuticals Private Limited.

The current boards of Habibar Rahman's companies include Aman Aziz Abdullah (Radial Pharmaceuticals Private Limited), Dewan Matiwur Rahman (Radial Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available